Last reviewed · How we verify

NCT03303768: CoA

Antenatal Diagnosis of Coarctations of the Aorta.

Completed Last updated 14 May 2019
What this trial tests

trial testing Ultrasound in Coarctation of Aorta in 20 participants. Completed in 29 August 2018.

Timeline
1 September 2017
Primary endpoint
29 August 2018
29 August 2018

Quick facts

Lead sponsorHospices Civils de Lyon
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 September 2017
Primary completion29 August 2018
Estimated completion29 August 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

18 and older, female only, with Coarctation of Aorta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prenatal diagnosis of coarctation is difficult because the ductus arteriosus masks the isthmus narrowing. The problem lies in the fact that it is difficult to assert in utero diagnosis and to predict severity of neonatal symptomatology. However, it is essential to try to establish the diagnosis since it has been shown that the prenatal diagnosis improves survival and reduces morbidity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Coarctation of Aorta

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03303768.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing